Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

Widespread COVID-19 vaccinations not expected until mid-2021, says WHO

Potential candidates must prove robust efficacy and safety first

- PMLiVE

AbbVie signs immunotherapy pact with I-Mab worth $2bn

Focus of deal is anti-CD47 monoclonal antibody lemzoparlimab

- PMLiVE

Russia’s COVID-19 vaccine demonstrates early potential in Lancet report

However, there is too little data to definitively confirm efficacy

In the precision medicine era, the line between products and services is blurred

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

Blue Latitude Health

- PMLiVE

Gavi says 76 wealthy countries have committed to COVAX vaccine facility

Countries have signed intent to joining COVID-19 vaccine initiative

Leveraging Data, Technology & Expertise to Solve Problems & Transform Healthcare

Tushar Pant, Consulting Executive in Healthcare at IBM, discusses how technology is transforming healthcare. Among many other things, we explore how IBM is working to improve the healthcare industry in Canada,...

Impetus Digital

Reimagining Healthcare Through Integrated Digital Health Empowerment

Yianni Serpanos, Founder & CEO of HealthTechX, discusses a variety of topics, including how COVID-19 has affected the uptake of telehealth among allied health professionals in Australia and worldwide. Yianni also...

Impetus Digital

- PMLiVE

Porterhouse Medical Hub, Nottingham: The latest development for the Porterhouse Medical Group

As part of our continued expansion and the expansion of imc group, Porterhouse Medical Group, global insight-led scientific and medical communications agency, is delighted to announce the opening of our latest...

Porterhouse Medical Group

- PMLiVE

Digital Therapeutics Landscape in Europe

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

OPEN Health

- PMLiVE

Standard steroid improves recovery of critically-ill COVID-19 patients

The study evaluated hydrocortisone in 403 patients with suspected or confirmed COVID-19

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Inizio

- PMLiVE

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

OPEN Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links